FIELD: pharmacology.
SUBSTANCE: 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable derivative thereof are applied. Application of a single dose of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methyl-benzamide or a pharmaceutically acceptable derivative thereof, using 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methyl-benzamide in the drug manufacture, method of treating acute attacks of chronic obstructive pulmonary disease, a drug for oralinjection comprising 3-[5-amino-4-(3-cyanobenzoyl)-pirasol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable derivative thereof are also proposed.
EFFECT: treatment of acute attacks of chronic obstructive pulmonary disease.
17 cl, 5 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DOSING REGIMEN FOR TREATING ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2713203C1 |
| DOSING REGIMEN FOR TREATING ACUTE EXACERBATIONS OF INFLAMMATORY CONDITIONS | 2016 |
|
RU2709509C1 |
| SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | 2014 |
|
RU2683793C2 |
| HYDANTOIN DERIVATIVES USED AS MMP INHIBITORS | 2007 |
|
RU2463301C2 |
| PHARMACEUTICAL COMPOSITION EXHIBITING ANTI-INFLAMMATORY, PARTICULARLY ANTIASTHMATIC ACTION, APPLICATIONS OF PHARMACEUTICAL COMPOSITION (VERSIONS) AND DRUG (VERSIONS) | 2008 |
|
RU2406498C2 |
| METHODS OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH USE OF BENRALIZUMAB | 2014 |
|
RU2706729C2 |
| METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3-CYANOBENZOYL)PYRAZOLE-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE | 2017 |
|
RU2792728C2 |
| THERAPEUTIC USE OF EKTOIN | 2012 |
|
RU2648475C2 |
| METHOD FOR PRODUCING POLYMORPH FORM OF 3-[5-AMINO-4-(3-CYANOBENZOYL)PYRAZOLE-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE | 2017 |
|
RU2765719C2 |
| AMINOPYRAZOLES AS SELECTIVE JANUS KINASE INHIBITORS | 2017 |
|
RU2757218C2 |
